Dr. Adnan M. Mjalli

Executive Chairman

Dr. Adnan M. M. Mjalli is an internationally recognized serial entrepreneur in the business of drug discovery and development of new medicines in the pharmaceutical and biotechnology space, in addition to novel therapies derived from Human and Earth Biome technologies Including bioremediation.

Rob Andrews

Chief Scientific Officer

Dr. Robert Andrews is an experienced strategic and tactical manager and researcher in organic and medicinal chemistry, drug design and discovery, and pharmaceutical development, providing solutions to difficult problems in these fields.

Clement Erhardt

Chief Legal Counsel

Mr. Erhardt’s career has focused exclusively on consumer products. Prior to joining MIG USA, Erhardt served for 8 years as Global General Counsel for Market America, a Greensboro, NC health and wellness company specializing in direct sales of dietary supplements, personal care goods, and cosmetics.

Giulia Benvenuto

Executive Assistant

Giulia Benvenuto holds a bachelor’s degree in Political Science and International Relations, as well as a Master's degree in Middle Eastern Studies from Harvard University.

Stephen Holcombe

Chief Financial Advisor

Stephen L. Holcombe, former President and Chief Executive Officer of vTv Therapeutics, serves as MIG USA Financial Advisor.